human
adenovirus
hadv
common
caus
communityacquir
infect
immunocompet
individu
adenoviru
infect
often
manifest
upper
respiratori
tract
infect
pharyngoconjunctiv
fever
diarrhoea
case
viral
respiratori
pathogen
commun
outbreak
adenoviru
infect
may
occur
especi
respiratori
tract
infect
keratoconjunct
outbreak
may
carri
substanti
morbid
mortal
particularli
term
sever
respiratori
tract
involv
immunocompromis
host
adenoviru
infect
may
present
respiratori
tract
infect
hepat
enter
haemorrhag
cystiti
dissemin
infect
graft
loss
organ
transplant
recipi
high
risk
individu
includ
patient
primari
immunodefici
especi
sever
combin
immunodefici
syndrom
allogen
haematopoiet
stem
cell
transplant
solid
organ
transplant
recipi
dissemin
diseas
immunocompromis
patient
may
carri
casefat
ratio
current
seven
speci
hadv
g
serotyp
certain
speciesserotyp
characterist
associ
organspecif
infect
exampl
adenovir
keratoconjunct
often
associ
speci
enter
infect
often
caus
respiratori
tract
infect
one
commonest
manifest
hadv
infect
frequent
due
speci
b
c
consider
geograph
variat
preval
variou
speci
serotyp
caus
respiratori
tract
infect
recent
studi
china
malaysia
croatia
usa
exampl
speci
c
often
commonest
serotyp
involv
communityacquir
respiratori
tract
infect
follow
speci
b
serotyp
frequent
detect
similarli
speci
c
one
commonest
speci
involv
infect
among
immunocompromis
patient
understand
epidemiolog
preval
variou
hadv
speci
serotyp
ideal
within
one
local
import
order
choos
appropri
diagnost
modal
demonstr
good
sensit
specif
toward
clinic
import
strain
convent
viral
cultur
larg
supplant
nucleic
acid
amplif
test
diagnosi
adenoviru
infect
detect
adenovir
dna
nucleic
acid
amplif
offer
excel
sensit
shorter
turnaround
time
viral
cultur
also
power
tool
discoveri
novel
virus
nucleic
acid
amplif
assay
also
allow
easier
determin
viral
serotyp
quantif
viral
load
clinic
specimen
determin
viral
load
especi
import
immunocompromis
host
higher
risk
develop
sever
dissemin
infect
well
establish
high
level
hadv
dnaemia
portend
dissemin
diseas
monitor
viral
load
peripher
blood
stool
suscept
host
may
role
earli
diagnosi
preemptiv
treatment
high
risk
individu
viral
load
studi
also
use
monitor
respons
antivir
therapi
cidofovir
number
studi
publish
develop
hadv
quantit
pcr
qpcr
protocol
previous
develop
qpcr
assay
detect
hadv
serotyp
shown
persist
hadv
lower
respiratori
tract
common
among
immunocompromis
host
even
without
clinic
adenovir
infect
viral
load
correl
low
absolut
lymphocyt
count
recent
year
commerci
qpcr
assay
kit
avail
specif
detect
hadv
facilit
diagnosi
monitor
hadv
infect
clinic
laboratori
adenoviru
pcr
also
includ
number
commerci
multiplex
pcr
system
clinic
diagnost
shown
newer
technolog
resequenc
microarray
could
also
use
diagnosi
gastroenter
conjunct
due
hadv
pcr
assay
primer
probe
either
speci
typespecif
base
mismatch
compar
hexon
gene
sequenc
hadv
strain
avail
genbank
henc
attempt
design
primerprob
set
cover
hadv
speci
g
compar
perform
inhous
hadv
qpcr
protocol
commerci
assay
use
archiv
clinic
specimen
profici
test
sampl
perform
characterist
inhous
laboratorydevelop
hadv
qpcr
assay
evalu
refer
adenoviru
pcr
kit
analyt
sensit
lod
lowest
concentr
hadv
dna
detect
replic
inhous
assay
lod
plasma
copiesml
ci
copiesml
vtm
copiesml
ci
copiesml
tabl
lloq
determin
calcul
sd
use
concentr
replic
shown
posit
hadv
tabl
lloq
plasma
vtm
copiesml
copiesml
respect
base
sd
greater
copiesml
tabl
sd
valu
replic
concentr
copiesml
plasma
copiesml
vtm
greater
copiesml
data
shown
analyt
specif
inhous
hadv
qpcr
assay
evalu
inhous
assay
show
cross
reaction
cytomegaloviru
epsteinbarr
viru
varicellazost
viru
herp
simplex
viru
type
human
herpesviru
bk
viru
jc
viru
hepat
b
c
virus
parvoviru
human
bocaviru
respiratori
syncyti
viru
human
metapneumoviru
human
parainfluenza
viru
human
coronavirus
sar
merscov
human
enteroviru
rhinoviru
human
parechoviru
influenza
virus
b
c
test
inhous
hadv
qpcr
assay
across
rang
detect
plasma
vtm
copiesml
demonstr
excel
agreement
expect
observ
viral
load
coeffici
determin
respect
fig
replic
experi
evalu
intra
interassay
variat
total
imprecis
cv
valu
concentr
rang
plasma
vtm
tabl
inhous
hadv
qpcr
assay
abl
detect
six
adenoviru
speci
f
clinic
eqa
sampl
speci
g
detect
studi
among
clinic
specimen
eqa
sampl
subject
hadv
dna
load
quantif
posit
b
c
e
f
speci
identifi
blastn
search
ncbi
websit
use
partial
hexon
gene
sequenc
neg
inhous
commerci
assay
see
addit
file
pcr
inhibit
observ
reaction
assay
use
adenoviru
pcr
kit
refer
sensit
specif
inhous
qpcr
assay
respect
tabl
one
sampl
detect
inhous
assay
detect
adenoviru
pcr
assay
exclud
linear
regress
analysi
good
agreement
perform
inhous
hadv
qpcr
assay
compar
assay
demonstr
strong
correl
coeffici
determin
fig
blandaltman
plot
show
mean
differ
copiesml
two
assay
sd
fig
clinic
sampl
test
posit
adenoviru
pcr
kit
neg
inhous
assay
subject
partial
hexon
gene
pcr
partial
hexon
gene
could
amplifi
sampl
anoth
sampl
test
posit
inhous
commerci
assay
partial
hexon
gene
could
amplifi
like
due
low
viral
load
sampl
copiesml
eqa
sampl
evalu
inhous
hadv
qpcr
assay
could
give
viral
load
valu
close
consensu
valu
report
cap
qcmd
within
accept
criteria
eqa
sampl
consensu
valu
sd
see
addit
file
data
ie
consensu
result
sampl
qcmd
came
extern
qualiti
assess
studi
part
formal
method
comparison
nucleic
acid
amplif
test
becom
one
import
laboratori
diagnost
tool
clinic
virolog
addit
high
sensit
test
rel
eas
quantifi
viral
load
short
turnaround
time
compar
convent
viral
cultur
abil
detect
antivir
resist
gene
mutat
provid
clinic
relev
inform
diagnosi
monitor
patient
variou
viral
infect
commerci
pcr
kit
wide
avail
detect
mani
common
viral
pathogen
offer
advantag
rel
simplic
test
procedur
well
character
perform
manufactur
mani
case
degre
autom
integr
laboratori
workflow
howev
avail
commerci
kit
remain
limit
less
commonli
encount
pathogen
hadv
well
known
caus
respiratori
enter
infect
commun
outbreak
due
hadv
may
involv
individu
institut
includ
militari
recruit
hadv
vaccin
specif
develop
usa
sever
respiratori
tract
involv
import
complic
adenoviru
infect
even
immunocompet
individu
immunocompromis
host
especi
children
high
risk
develop
sever
sometim
dissemin
adenoviru
infect
high
mortal
best
knowledg
two
commerci
avail
hadv
qpcr
test
kit
time
write
adenoviru
pcr
kit
altona
diagnost
adenoviru
current
studi
compar
inhous
laboratorydevelop
hadv
qpcr
protocol
adenoviru
pcr
kit
inhous
protocol
adapt
avail
molecular
diagnost
facil
clinic
laboratori
although
number
research
develop
qpcr
assay
diagnosi
monitor
adenoviru
infect
mani
previou
test
intrins
limit
speciesspecif
socal
panadenoviru
assay
still
show
base
mismatch
primersprob
target
gene
sequenc
hadv
avail
genbank
see
addit
file
exampl
one
assay
includ
three
serotyp
speci
b
anoth
studi
forward
primer
contain
base
mismatch
speci
mismatch
speci
b
mismatch
speci
mismatch
speci
e
mismatch
speci
f
mismatch
speci
g
revers
primer
contain
mismatch
speci
f
probe
contain
mismatch
speci
g
one
studi
show
improv
detect
hadv
speci
g
use
sever
forward
revers
primer
probe
cover
speci
singl
reaction
mismatch
still
observ
primer
probe
studi
one
primerprob
set
use
use
highli
conserv
primer
probe
sequenc
forward
revers
primer
set
base
mismatch
near
end
primer
type
speci
b
f
probe
develop
studi
base
mismatch
affect
detect
inhous
assay
abl
detect
two
strain
clinic
sampl
silico
analysi
also
suggest
primer
probe
set
abl
detect
speci
g
although
speci
g
strain
collect
confirm
inhous
qpcr
assay
shown
specif
hadv
crossreact
human
viral
pathogen
compar
favour
adenoviru
pcr
kit
also
specif
test
differ
viral
bacteri
agent
unlik
commerci
kit
evalu
seven
speci
g
hadv
inhous
assay
test
speci
f
speci
g
sampl
archiv
diagnost
perform
inhous
assay
evalu
use
clinic
specimen
eqa
sampl
hadv
speci
confirm
partial
sequenc
hexon
gene
inhous
assay
achiev
high
sensit
compar
commerci
kit
correl
two
assay
good
inhous
assay
linear
rang
copiesml
compar
studi
low
intra
interassay
variat
reflect
cv
valu
time
write
one
publish
studi
evalu
altona
pcr
assay
inhous
hadv
qpcr
test
refer
centr
studi
also
show
good
correl
perform
altona
inhous
assay
howev
hadv
speci
b
c
f
includ
studi
major
strain
speci
b
c
cost
pcr
reagent
inhous
assay
us
per
reaction
much
lower
adenoviru
pcr
kit
us
per
reaction
thu
inhous
assay
may
serv
valuabl
tool
lowcost
accur
detect
quantit
hadv
dna
user
expertis
develop
inhous
assay
eg
primer
probe
design
recombin
plasmid
prepar
adenoviru
pcr
kit
would
altern
quantit
detect
hadv
laboratori
good
diagnost
perform
develop
inhous
qpcr
assay
detect
quantit
hadv
speci
g
perform
assay
correl
well
commerci
avail
altona
adenoviru
pcr
kit
compar
sensit
specif
linear
dynam
rang
one
hundr
twenti
two
archiv
clinic
specimen
submit
depart
microbiolog
queen
mari
hospit
subject
hadv
test
includ
plasma
serum
cerebrospin
fluid
csf
respiratori
specimen
includ
bronchoalveolar
lavag
endotrach
aspir
nasal
swab
nasopharyng
swab
aspir
throat
swab
tracheal
aspir
sputum
stool
rectal
swab
urin
eye
swab
skin
swab
biopsi
specimen
see
addit
file
clinic
valid
sampl
includ
plasma
andor
transport
medium
variou
concentr
hadv
neg
hadv
colleg
american
pathologist
cap
qualiti
control
molecular
diagnost
qcmd
use
extern
qualiti
assess
eqa
sampl
store
prior
test
plasma
serum
csf
respiratori
urin
stool
specimen
swab
subject
total
nucleic
acid
tna
extract
nuclisen
easymag
extract
system
marcyl
franc
elut
volum
respect
around
mg
tissu
sampl
biopsi
extract
qiaamp
dna
mini
kit
qiagen
hilden
germani
elut
volum
accord
manufactur
instruct
order
design
set
primer
probe
detect
hadv
speci
perform
multipl
sequenc
align
hexon
gene
variou
type
hadv
speci
g
use
bioedit
version
number
mismatch
hexon
gene
sequenc
hadv
strain
avail
genbank
differ
primerprob
set
adopt
studi
also
identifi
primer
probe
use
hadv
qpcr
monitor
pcr
inhibit
shown
tabl
reaction
mixtur
contain
quantinova
probe
pcr
master
mix
qiagen
germani
primer
probe
sampl
templat
tnadna
inhous
qpcr
assay
perform
instrument
ii
roch
rotkreuz
switzerland
pcr
condit
consist
cycl
min
follow
cycl
sampl
run
parallel
use
adenoviru
pcr
kit
altona
diagnost
gmbh
hamburg
germani
reaction
volum
contain
templat
accord
manufactur
instruct
monitor
pcr
inhibit
inhous
qpcr
assay
intern
control
primer
probe
plasmid
dna
bp
insert
copi
use
previou
studi
ad
reaction
plasmid
standard
prepar
use
pcriitopo
vector
invitrogen
carlsbad
usa
clone
target
insert
bp
hexon
gene
hadv
plasmid
stock
dilut
ae
buffer
prepar
work
stock
aliquot
store
work
stock
dilut
ae
buffer
final
concentr
quantif
standard
inhous
qpcr
assay
plasmid
concentr
use
strong
weak
posit
control
respect
monitor
potenti
cross
contamin
pcr
setup
notempl
control
pcrgrade
water
ad
well
contain
reaction
mixtur
neg
control
hadvposit
sampl
subject
partial
hexon
gene
sequenc
speci
identif
convent
pcr
perform
use
primer
modifi
previou
studi
tabl
pcr
mixtur
contain
templat
sampl
templat
firstround
pcr
firstround
pcr
product
nest
pcr
pcr
buffer
ii
mm
dntp
primer
u
taq
polymeras
appli
biosystem
foster
citi
usa
firstround
nest
pcr
perform
use
autom
thermocycl
appli
biosystem
foster
citi
usa
hot
start
min
follow
cycl
min
min
min
final
extens
min
pcr
product
detect
agaros
gel
electrophoresi
strand
pcr
product
sequenc
abi
dna
analyz
appli
biosystem
usa
use
pcr
primer
hadv
speci
determin
blast
search
ncbi
websit
inhous
hadv
qpcr
assay
subject
evalu
term
analyt
sensit
specif
linear
precis
accuraci
analyt
sensit
lod
identifi
evalu
dilut
seri
hadvneg
plasma
viral
transport
medium
vtm
matric
spike
recombin
plasmid
concentr
copiesml
plasma
copiesml
vtm
subject
tna
extract
describ
tabl
lloq
determin
two
independ
run
concentr
test
replic
plasmid
dna
concentr
measur
biodrop
biodrop
uk
doublestrand
dna
copi
number
calcul
http
celsuriedugsccndnahtml
use
convert
definit
amount
plasmid
dna
spike
ml
matrix
plasmavtm
follow
serial
dilut
obtain
differ
concentr
test
analyt
specif
crossreact
determin
test
genom
dnarna
extract
virus
caus
similar
symptom
adenoviru
infect
linear
rang
inhous
qpcr
assay
evalu
analyz
dilut
seri
hadvneg
plasma
vtm
matric
spike
plasmid
concentr
lloq
copiesml
triplic
concentr
intraassay
variat
evalu
use
hadvneg
plasma
vtm
matric
spike
plasmid
concentr
span
report
rang
lloq
copiesml
triplic
concentr
singl
run
interassay
variat
evalu
sampl
concentr
lloq
copiesml
triplic
concentr
two
independ
experi
tabl
coeffici
variat
cv
sdmean
calcul
concentr
probit
regress
analysi
determin
detect
limit
inhous
hadv
qpcr
assay
perform
describ
previous
lloq
defin
lowest
dilut
sd
within
copiesml
withinrun
betweenrun
precis
inhous
qpcr
method
quantifi
hadv
dna
express
coeffici
variat
cv
agreement
inhous
qpcr
assay
adenoviru
pcr
kit
determin
use
blandaltman
plot
sampl
posit
inhous
commerci
assay
correl
viral
load
obtain
inhous
commerci
assay
perform
linear
regress
analysi
statist
analysi
perform
use
ibm
spss
statist
